These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24647260)

  • 21. Update on Vaccine-Derived Polioviruses - Worldwide, January 2016-June 2017.
    Jorba J; Diop OM; Iber J; Henderson E; Sutter RW; Wassilak SGF; Burns CC
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1185-1191. PubMed ID: 29095803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza.
    Lasch EE; Abed Y; Abdulla K; El Tibbi AG; Marcus O; El Massri M; Handscher R; Gerichter CB; Melnick JL
    Rev Infect Dis; 1984; 6 Suppl 2():S467-70. PubMed ID: 6740094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR finding in vaccine-associated paralytic poliomyelitis.
    Wiwanitkit V
    Pediatr Radiol; 2010 Sep; 40(9):1583; author reply 1584. PubMed ID: 20567967
    [No Abstract]   [Full Text] [Related]  

  • 24. Inactivated poliovirus vaccine and vaccine-associated paralytic poliomyelitis.
    Brown B
    JAMA; 1997 Jan 22-29; 277(4):295. PubMed ID: 9002483
    [No Abstract]   [Full Text] [Related]  

  • 25. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.
    Breiman RF; Brooks WA; Goswami D; Lagos R; Borja-Tabora C; Lanata CF; Londoño JA; Lum LC; Rappaport R; Razmpour A; Walker RE; Gruber WC; Forrest BD
    Vaccine; 2009 Sep; 27(40):5472-9. PubMed ID: 19616493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.
    Strebel PM; Aubert-Combiescu A; Ion-Nedelcu N; Biberi-Moroeanu S; Combiescu M; Sutter RW; Kew OM; Pallansch MA; Patriarca PA; Cochi SL
    Am J Epidemiol; 1994 Dec; 140(12):1111-24. PubMed ID: 7998593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reporting vaccine-associated paralytic poliomyelitis: concordance between the CDC and the National Vaccine Injury Compensation Program.
    Weibel RE; Benor DE
    Am J Public Health; 1996 May; 86(5):734-7. PubMed ID: 8629730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paralytic poliomyelitis--United States, 1980-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parental knowledge and choice regarding live and inactivated poliovirus vaccines.
    Thoms ML; Bodnar PZ; O'Donovan JC; Gouel EG; Walcher JR; Halsey NA
    Arch Pediatr Adolesc Med; 1997 Aug; 151(8):809-12. PubMed ID: 9265883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological morbidity in vaccine-associated paralytic poliomyelitis in Brazil from 1989 up to 1995.
    Dias-Tosta E; Kückelhaus CS
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):414-20. PubMed ID: 15273837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The logic of causation and the risk of paralytic poliomyelitis for an American child.
    Ridgway D
    Epidemiol Infect; 2000 Feb; 124(1):113-20. PubMed ID: 10722138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention - is it useful?].
    Valsecchi M
    Ig Sanita Pubbl; 2016; 72(1):69-76. PubMed ID: 27266054
    [No Abstract]   [Full Text] [Related]  

  • 34. Poliomyelitis associated with oral poliovaccine. Report on two cases.
    Haneberg B; Orstavik I
    Acta Paediatr Scand; 1972 Jan; 61(1):105-8. PubMed ID: 5018571
    [No Abstract]   [Full Text] [Related]  

  • 35. Apropos risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Arya SC; Agarwal N
    Expert Rev Vaccines; 2012 Nov; 11(11):1291. PubMed ID: 23249227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.
    Strebel PM; Ion-Nedelcu N; Baughman AL; Sutter RW; Cochi SL
    N Engl J Med; 1995 Feb; 332(8):500-6. PubMed ID: 7830731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substantia nigra lesions in rhesus monkeys injected with attenuated polioviruses.
    Arya SC
    J Biol Stand; 1976; 4(4):337-9. PubMed ID: 825516
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccine-associated polio: a case and its lessons.
    Mashikian MV; Stollerman GH
    Hosp Pract (Off Ed); 1994 Sep; 29(9):69-73, 76-7. PubMed ID: 8083327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.
    Steele AD; De Vos B; Tumbo J; Reynders J; Scholtz F; Bos P; de Beer MC; Van der Merwe CF; Delem A
    Vaccine; 2010 Sep; 28(39):6542-8. PubMed ID: 18786585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.